BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31941451)

  • 1. C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy.
    Xing Y; Li L; Zhang Y; Wang F; He D; Liu Y; Jia J; Yan T; Lin S
    BMC Nephrol; 2020 Jan; 21(1):18. PubMed ID: 31941451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosylation of IgA1 Is Associated with Common Variation in
    Gale DP; Molyneux K; Wimbury D; Higgins P; Levine AP; Caplin B; Ferlin A; Yin P; Nelson CP; Stanescu H; Samani NJ; Kleta R; Yu X; Barratt J
    J Am Soc Nephrol; 2017 Jul; 28(7):2158-2166. PubMed ID: 28209808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
    Wang C; Ye M; Zhao Q; Xia M; Liu D; He L; Chen G; Peng Y; Liu H
    Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome.
    Liu Y; Wang F; Zhang Y; Jia J; Yan T
    J Cell Mol Med; 2020 Sep; 24(18):10493-10500. PubMed ID: 32677771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
    Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
    Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
    He L; Peng Y; Liu H; Yin W; Chen X; Peng X; Shao J; Liu Y; Liu F
    Am J Nephrol; 2013; 38(4):321-32. PubMed ID: 24107646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
    Suzuki H; Raska M; Yamada K; Moldoveanu Z; Julian BA; Wyatt RJ; Tomino Y; Gharavi AG; Novak J
    J Biol Chem; 2014 Feb; 289(8):5330-9. PubMed ID: 24398680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy.
    Qin W; Zhou Q; Yang LC; Li Z; Su BH; Luo H; Fan JM
    J Intern Med; 2005 Nov; 258(5):467-77. PubMed ID: 16238683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1 mimics the effect of IL-4 on the glycosylation of IgA1 by downregulating core 1 β1, 3-galactosyltransferase and Cosmc.
    Xiao J; Wang M; Xiong D; Wang Y; Li Q; Zhou J; Chen Q
    Mol Med Rep; 2017 Feb; 15(2):969-974. PubMed ID: 28035353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsaicin induces high expression of BAFF and aberrantly glycosylated IgA1 of tonsillar mononuclear cells in IgA nephropathy patients.
    Shao J; Peng Y; He L; Liu H; Chen X; Peng X
    Hum Immunol; 2014 Oct; 75(10):1034-9. PubMed ID: 25167771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy.
    Serino G; Sallustio F; Cox SN; Pesce F; Schena FP
    J Am Soc Nephrol; 2012 May; 23(5):814-24. PubMed ID: 22362909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro.
    Lin L; Shen J; Wu X; You Y; Li S
    J Vis Exp; 2023 Oct; (200):. PubMed ID: 37902367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy.
    Li GS; Zhang H; Lv JC; Shen Y; Wang HY
    Kidney Int; 2007 Mar; 71(5):448-53. PubMed ID: 17228361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
    Liu Y; Liu X; Jia J; Zheng J; Yan T
    J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy.
    Zhai YL; Zhu L; Shi SF; Liu LJ; Lv JC; Zhang H
    Medicine (Baltimore); 2016 Mar; 95(11):e3099. PubMed ID: 26986150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy.
    Liu Y; Zheng J; Jia J; Li H; Hu S; Lin Y; Yan T
    Ren Fail; 2019 Nov; 41(1):370-376. PubMed ID: 31057023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between
    Wang YN; Zhou XJ; Chen P; Yu GZ; Zhang X; Hou P; Liu LJ; Shi SF; Lv JC; Zhang H
    J Am Soc Nephrol; 2021 Mar; 32(3):545-552. PubMed ID: 33593824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy.
    Xie LS; Qin W; Fan JM; Huang J; Xie XS; Li Z
    Clin Invest Med; 2010 Feb; 33(1):E5-13. PubMed ID: 20144270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion
    Liu C; Li X; Shuai L; Dang X; Peng F; Zhao M; Xiong S; Liu Y; He Q
    Front Pharmacol; 2021; 12():658236. PubMed ID: 33935780
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-17 promotes the production of underglycosylated IgA1 in DAKIKI cells.
    Lin JR; Wen J; Zhang H; Wang L; Gou FF; Yang M; Fan JM
    Ren Fail; 2018 Nov; 40(1):60-67. PubMed ID: 29299950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.